The latest immunotherapy news and developments
Mount Sinai researchers have solved one of the enduring mysteries of cancer immunotherapy: Why does…
In a new study, researchers at Uppsala University, Sweden, have been able to show differences…
Breast cancer is the most common cancer in women worldwide, but many immunotherapies have had…
Adding an immune checkpoint inhibitor to the standard chemotherapy regimen for patients with early-stage breast…
Combining a gene-targeted drug, a cancer-bursting virus and a drug that removes the immune system’s…
A new approach to cancer therapy shows potential to transform the commonly used chemotherapy drug…
CD58 aberrations limit durable responses to CD19 CAR in large B cell lymphoma patients treated…
A procedure that may help personalise anticancer therapies has just been developed by the CNRS,…
Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy…
Immune-system T cells have been reprogrammed into regenerative stem cell-like memory (TSCM) cells that are…